DK101982A - Fremgangsmaade til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mikroorganisme - Google Patents

Fremgangsmaade til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mikroorganisme Download PDF

Info

Publication number
DK101982A
DK101982A DK101982A DK101982A DK101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A DK 101982 A DK101982 A DK 101982A
Authority
DK
Denmark
Prior art keywords
genes
pathogenic microorganism
vaccine
prevention
mammal
Prior art date
Application number
DK101982A
Other languages
English (en)
Other versions
DK172670B1 (da
Inventor
W S Dallas
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of DK101982A publication Critical patent/DK101982A/da
Application granted granted Critical
Publication of DK172670B1 publication Critical patent/DK172670B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198201019A 1981-03-09 1982-03-09 Fremgangsmåde til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mi DK172670B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24159481A 1981-03-09 1981-03-09
US24159481 1981-03-09

Publications (2)

Publication Number Publication Date
DK101982A true DK101982A (da) 1982-09-10
DK172670B1 DK172670B1 (da) 1999-05-10

Family

ID=22911341

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198201019A DK172670B1 (da) 1981-03-09 1982-03-09 Fremgangsmåde til fremstilling af en vaccine til hindring af gastroenterisk sygdom fremkaldt i et pattedyr af en patogen mi

Country Status (9)

Country Link
EP (1) EP0060129B1 (da)
JP (1) JP2554611B2 (da)
AT (1) ATE47961T1 (da)
AU (1) AU559550B2 (da)
CA (1) CA1201076A (da)
DE (1) DE3280019D1 (da)
DK (1) DK172670B1 (da)
NZ (1) NZ199866A (da)
WO (1) WO1982003088A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
EP0084522A3 (de) * 1982-01-18 1983-10-19 Sandoz Ag Neue Plasmide und Bakterienstämme sowie Verfahren zu ihrer Herstellung
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
GB8314645D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Bivalent vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
AU619908B2 (en) * 1984-02-01 1992-02-06 Enterovax Research Pty. Ltd. Bacterial strains
AU589114B2 (en) * 1984-02-01 1989-10-05 Enterovax Limited Genetically engineered bacteria useful as a vaccine
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
ES8705033A1 (es) * 1984-12-04 1987-04-16 Biotech Australia Pty Ltd Un metodo para preparar una vacuna para uso en el tratamiento prevencion de diarrea porcina neonatol.
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
JP2660511B2 (ja) * 1985-05-15 1997-10-08 バイオテクノロジ−・オ−ストラリア・ピ−テイ−ワイ・リミテツド 経口ワクチン
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
EP0264150B1 (fr) * 1986-10-13 1993-01-07 Solvay Microorganismes comportant des pili comme protéines porteuses, pili isolés à partir de ces microorganismes, procédé d'excrétion de peptides ou de protéines à l'aide de ces pili et utilisation de ceux-ci
FR2605017B1 (fr) * 1986-10-13 1989-10-06 Solvay Microorganismes comportant des pili comme proteines porteuses, pili isoles a partir de ces microorganismes et procede d'excretion de peptides ou de proteines a l'aide de ces pili.
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
US5162226A (en) * 1987-08-24 1992-11-10 University Of Tennessee Research Corp. (U.T.R.C.) Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
EP0314224B1 (en) * 1987-10-26 1992-05-27 Akzo N.V. Vaccine against e.coli septicaemia in poultry
US5079165A (en) * 1988-06-29 1992-01-07 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit in S. typhi
IL91525A0 (en) * 1988-09-06 1990-04-29 Univ Washington Transgenic plants,pharmaceutical compositions containing the same and methods for the preparation thereof
WO1998053082A1 (en) * 1997-05-21 1998-11-26 Daewoong Pharmaceutical Co., Ltd. A recombinant microorganism expressing an antigenic protein, adhesin
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
US7785778B2 (en) 2002-11-25 2010-08-31 University Of Copenhagen Porcine polymorphisms and methods for detecting them
SI1715755T1 (sl) 2004-02-03 2015-04-30 Prevtec Microbia Inc. Uporaba žive bakterije za pospeševanje rasti živali
MX2009013260A (es) * 2007-07-02 2010-01-25 Crucell Sweden Ab Operon hibrido para la expresion de los antigenos del factor de colonizacion de escherichia coli enterotoxica.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634858A (da) * 1962-07-19 1900-01-01
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2530275A1 (de) * 1975-07-07 1977-01-27 Max Planck Gesellschaft Salmonella-coli-hybride, verfahren zu deren herstellung und vermehrung und apathogener lebend-impfstoff gegen salmonellosen
NO158880C (no) * 1977-11-08 1988-11-09 Genentech Inc Fremgangsmaate for fremstilling av et spesifikt pattedyrhormon.
FR2442271A1 (fr) * 1978-11-27 1980-06-20 Pasteur Institut Vecteur permettant l'insertion d'un gene procaryote ou eucaryote, et l'excretion de la proteine exprimee
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype

Also Published As

Publication number Publication date
DE3280019D1 (en) 1989-12-21
AU559550B2 (en) 1987-03-12
ATE47961T1 (de) 1989-12-15
CA1201076A (en) 1986-02-25
AU8331082A (en) 1982-09-28
JPS57171926A (en) 1982-10-22
EP0060129A3 (en) 1983-06-01
DK172670B1 (da) 1999-05-10
WO1982003088A1 (en) 1982-09-16
JP2554611B2 (ja) 1996-11-13
EP0060129B1 (en) 1989-11-15
EP0060129A2 (en) 1982-09-15
NZ199866A (en) 1984-11-09

Similar Documents

Publication Publication Date Title
DE3280019D1 (en) Vaccines, a method for making vaccines and a method for stimulating antibody production
Koch The etiology of tuberculosis
DE69022290D1 (de) Lebende Impfstoffe.
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
FR07C0071I2 (fr) Culture de lawsonia intracellularis, vaccins anti-lawsonia intracellularis et agents de diagnostic
ES462588A1 (es) Procedimiento para la obtencion de vacunas, por tratamiento de microorganismos en un campo electrico de corriente alter-na.
DK0749321T3 (da) Aktiv immunisering under anvendelse af et sideroforreceptorprotein
DK0524205T3 (da) Levende vacciner
FI903154A0 (fi) Kimeriska glykoproteiner innehaollande immunogeniska segment av glykoproteiner av maenniskans respiratory syncytial-virus.
PT672116E (pt) Mutantes por supressao como vacinas contra a colera
Charlton et al. Skunk rabies
BR8807376A (pt) Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado
SE7610708L (sv) Forfarande for framstellning av ett antigent preparat
Li et al. Isolation of a non-neurotropic variant of type I poliomyelitis virus
ATE62270T1 (de) Herstellung des e.coli-lt-benterotoxinunterteils.
GB1413614A (en) Virus production
DK16087D0 (da) Mastitis-vaccine
US3422187A (en) Influenza vaccines and process for their manufacture
Lásaro et al. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains
DE3582422D1 (de) Biologische zubereitungen.
JPS56131385A (en) Cultivation of virus of hydrophobia
Larson A serum protection test in tularemic infections in white rats
KR850700110A (ko) 백신 및 이의 제조방법
Mitchell et al. Antibody Production in Milk Serum After Virus Instillation of Goat Mammary Gland VI.“Sham Infection” with Special Reference to Rabies
Wiblin , JL Melnick (Ed.) Progress in Medical Microbiology, Vol. 31, S. Karger (1985)

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired